Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D01ZPY
|
|||
| Former ID |
DIB007035
|
|||
| Drug Name |
FMP2.1/AS02A
|
|||
| Synonyms |
AMA-1 malaria vaccine; Recombinant protein vaccine (Plasmodium falciparum infection), WRAIR/NIAID; Apicalmembrane antigen-1 vaccine (malaria), NIAID/WRAIR
Click to Show/Hide
|
|||
| Indication | Malaria [ICD-11: 1F40-1F45; ICD-10: B50-B64, B54] | Phase 2 | [1] | |
| Company |
Walter Reed Army Institute of Research
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00460525) Phase II AMA-1 Malaria Vaccine FMP2.1/AS02A Trial in Mali. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.